flow trial semaglutide nejm effects of on chronic kidney disease 🚨#FLOW: The most anticipated the year now published in @NEJM Effects of Semaglutide Semaglutide, Chronic Kidney Disease, and

GLP-1 medications such as semaglutide and tirzepatide (brand names Ozempic, Wegovy, Mounjaro, Zepbound) have emerged as breakthrough medications for promoting weight loss and managing Type 2 diabetes

They were given 2.4mg of once-weekly subcutaneous semaglutide injections or a placebo over 64 weeks

If you believe an error was made in your prescription or delivery, please contact us at [email protected] or call (512) 400-4213 and our team will make it right.

Dietary modifications are often the first-line approach: Eat smaller, more frequent meals rather than large portions, as this reduces the burden on your slowed digestive system